Clinical Trial Update: Hemorrhagic Brainstem Cavernous Malformations Treatment With Sirolimus: aSingle Centre, Randomized, Placebo-controlled Pilot Trial [Phase 2]

View source ↗

Summary

A Phase 2, single-centre randomized, placebo-controlled pilot trial is evaluating sirolimus for hemorrhagic brainstem cavernous malformations, with recruitment …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brainstem Stroke
• Cavernous Malformations of the Brain
• Intracerebral Hemorrhage

Drugs mentioned

• Rapamune (sirolimus)

Snippet

Sponsor: Huashan Hospital | Conditions: Cavernous Malformations, Intracerebral Hemorrhage | Phase 2 | Status: RECRUITING